EUVIMEDEUVIMED entdecken
Crossref

A 3D Cell Culture Platform for Evaluating Macrophage‐Liposome Conjugates in Combination Chemotherapy

Chia-Chen Kuo, Wei-Yu Liao, Yu-Jung Lin iD, Chau-Hwang Lee iD

Journal of Biomedical Materials Research Part A · 2025

DOI: 10.1002/jbm.a.37939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2025. Verfasst von Chia-Chen Kuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Applied Sciences, Academia Sinica, Taipei, Taiwan. Hauptthemen laut MEDLINE: Liposomes, Macrophages, Paclitaxel, Cell Culture Techniques, Three Dimensional. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Academia Sinica, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophage‐based drug delivery systems, such as macrophage‐liposome conjugates (Mϕ‐Lip), leverage the natural tumor‐homing ability of macrophages and offer a potential solution for overcoming biological barriers and delivering chemotherapy drugs to challenging tumor regions. However, reliable platforms to assess the tumor‐targeting efficiency, penetration capabilities, and therapeutic effectiveness of drug‐laden macrophages remain largely unavailable. In this study, we developed a three‐dimensional (3D) cell culture platform that mimics the structural and biological complexity of in vivo tumors, enabling real‐time observation and analysis of Mϕ‐Lip as they migrate, penetrate, and exert anti‐tumor effects. Beyond evaluating the delivery process, this work focuses on the rational design and optimization of dosage regimens for co‐delivering cisplatin (CDDP) and paclitaxel (Taxol) using Mϕ‐Lip. Experimental results demonstrated that the drugs encapsulated within the liposomes influenced the invasive behavior of Mϕ‐Lip, which in turn impacted their tumor‐killing efficiency. Using this 3D cell culture platform, we identified optimal dosage regimens for co‐delivering combination chemotherapy drugs through the Mϕ‐Lip. This newly developed approach provides a reliable and versatile tool not only for evaluating but also for fine‐tuning cell‐based drug delivery strategies. It holds significant promise for advancing targeted chemotherapy strategies and improving therapeutic outcomes for solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesMacrophagesPaclitaxelCell Culture Techniques, Three DimensionalAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCisplatinAnimalsHumansMiceCell Line, TumorDrug Delivery Systems

Stichwörter der Autor:innen

3D cell culturecombination chemotherapyliposomemacrophage

Substanzen

LiposomesCisplatinPaclitaxelAntineoplastic Agents

Autor:innen und Institutionen

  • Research Center for Applied Sciences, Academia Sinica, Taipei, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Institute of Biophotonics, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Yu-Jung Lin, Chau-Hwang Lee

Förderung

  • Ministry of Science and Technology, Taiwan
  • Academia Sinica
  • National Science and Technology Council

Zitieren

APA

Kuo, C. C., Liao, W. Y., Lin, Y. J., & Lee, C. H. (2025). A 3D Cell Culture Platform for Evaluating Macrophage‐Liposome Conjugates in Combination Chemotherapy. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37939

Vancouver

Kuo CC, Liao WY, Lin YJ, Lee CH. A 3D Cell Culture Platform for Evaluating Macrophage‐Liposome Conjugates in Combination Chemotherapy. Journal of Biomedical Materials Research Part A. 2025. doi:10.1002/jbm.a.37939

BibTeX
@article{Kuo2025,
  author = {Kuo, Chia-Chen and Liao, Wei-Yu and Lin, Yu-Jung and Lee, Chau-Hwang},
  title = {A 3D Cell Culture Platform for Evaluating Macrophage‐Liposome Conjugates in Combination Chemotherapy},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2025},
  doi = {10.1002/jbm.a.37939}
}
Kostenlos starten →